About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
RNA Vaccines and Therapeutics
Autoimmune Disease
Clinical Trials
Publications & Events
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Publications & Events
Publications & Events
Publications & Events
Filter by Year:
2023
2022
2021
2020
18-Sep-2023
Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection
15-Nov-2022
CRO-67 is a Novel Therapeutic for Pancreatic Cancer: Implications for Tumour and Stromal Reprogramming
24-May-2022
Noxopharm collaborators Hudson Institute of Medical Research confirm the relevance of TLR7 activation in Lupus
21-Jun-2021
Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides
27-Jul-2020
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
1
